Adaptimmune Therapeutics plc

ADAP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$91,139$143,991$108,033$149,948
Short-Term Investments$60,466$2,947$96,572$219,632
Receivables$15,982$46,919$38,087$34,007
Inventory$7,320$0$0$0
Other Curr. Assets$13,262$13,695$12,678$11,871
Total Curr. Assets$188,169$207,552$255,370$415,458
Property Plant & Equip (Net)$51,218$71,708$71,535$51,369
Goodwill$0$0$0$0
Intangibles$3,880$330$442$1,000
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,696$3,026$1,569$1,718
Total NC Assets$57,794$75,064$73,546$54,087
Other Assets$0$0$0$0
Total Assets$245,963$282,616$328,916$469,545
Liabilities
Payables$8,692$8,128$4,753$8,113
Short-Term Debt$9,418$5,384$5,456$4,640
Tax Payable$0$1,398$0$0
Deferred Revenue$12,296$28,973$23,520$22,199
Other Curr. Liab.$34,121$28,905$20,904$23,843
Total Curr. Liab.$64,527$72,788$64,501$62,541
LT Debt$69,500$19,851$20,349$23,148
Deferred Rev, NC$95,815$149,060$160,892$177,223
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,272$1,404$1,296$673
Total NC Liab.$169,587$170,315$182,537$201,044
Other Liabilities$0$0$0$0
Cap. Leases$23,972$25,235$23,077$25,468
Total Liabilities$234,114$243,103$247,038$263,585
Equity
Pref Stock$0$0$0$0
Common Stock$2,085$1,865$1,399$1,337
Retained Earnings-$1,093,987-$1,023,173-$909,302-$743,846
AOCI-$1,902-$3,748-$875-$11,142
Other Equity$1,105,653$1,064,569$990,656$959,611
Total Equity$11,849$39,513$81,878$205,960
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$245,963$282,616$328,916$469,545
Net Debt-$12,221-$118,756-$82,228-$122,160
Adaptimmune Therapeutics plc (ADAP) Financial Statements & Key Stats | AlphaPilot